Leriglitazone-d4 (MIN-102-d4, Hydroxypioglitazone-d4) is deuterium labeled Leriglitazone. Leriglitazone is an orally active and a BBB-penetrable PPARgamma agonist with an EC50 of 9 µM. Leriglitazone, as a regulator of mitochondrial function, has neuroprotective, anti-inflammatory and antioxidant effects. Leriglitazone can be used in the study of neuroinflammatory and neurodegenerative diseases[1][2].
Molecular Weight:
376.46
CAS Number:
[1188263-49-1]
Formula:
C19H16D4N2O4S
Target:
Isotope-Labeled Compounds,PPAR
Application Notes:
MCE Product type: Isotope-Labeled Compounds
* VAT and and shipping costs not included. Errors and price changes excepted